News
12-09-2015, 02:54 AM
Combining the new breast cancer drug palbociclib with paclitaxel (Taxol) shrank tumors in nearly half of patient with estrogen-receptor (ER) positive breast cancer, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
More... (http://www.news-medical.net/news/20151209/Palbociclib-and-paclitaxel-combination-shrinks-tumors-in-patient-with-ER-positive-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20151209/Palbociclib-and-paclitaxel-combination-shrinks-tumors-in-patient-with-ER-positive-breast-cancer.aspx)